Multidrug-Resistant <i>Candida auris</i> Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020
Anuradha Chowdhary, Bansidhar Tarai, Ashutosh Singh, Amit Sharma
Abstract
In New Delhi, India, candidemia affected 15 critically ill coronavirus disease patients admitted to an intensive care unit during April-July 2020. Candida auris accounted for two thirds of cases; case-fatality rate was high (60%). Hospital-acquired C. auris infections in coronavirus disease patients may lead to adverse outcomes and additional strain on healthcare resources.
Topics & Concepts
Candida aurisMultiple drug resistanceMedicineCritically illVirologyCoronavirusDiseaseMicrobiologyDrug resistanceIntensive care medicineCoronavirus disease 2019 (COVID-19)BiologyInfectious disease (medical specialty)AntifungalInternal medicineCOVID-19 Clinical Research StudiesAntifungal resistance and susceptibilityLong-Term Effects of COVID-19